Upbound Group UPBD Rebounds From Support Resistance Test Ahead TrumpXi Summit Concludes 3 Key Takeaways for Global Markets Astera Labs Shares Rally Following Analyst Optimism Launchpad LPCV at 998 Buy Sell or Hold 20260520 US Retail Sales Rise 05 in April Matching Forecasts as Consumer Spending Holds Steady Could The Cigna Group CI Be Considered Among Dividend Growth Stocks for a MultiYear Hold Nvidia Data Center Revenue Nearly Doubles as Strong Earnings Report Prompts Stock Decline Wingstop Shares Slide 12 as Quarterly Profit Misses Analysts Expectations Tokyo Governor Promotes Hydrogen and AI Cooperation in Central Asia Visit APEC Meetings Reveal Persistent USChina Trade Rifts After TrumpXi Summit ZTS Q1 2026 Earnings EPS Falls Short of Expectations as Stock Edges Higher MTRN Q1 2026 Earnings EPS Surpasses Estimates by 64 Stock Rises Modestly RILYZ Q1 2024 Earnings Negative EPS Reflects Challenging Quarter for BRC Group Holdings Freedom Holding Corp Q1 2026 Earnings EPS of 125 Reported as Stock Declines BNR Q3 2022 Earnings Narrower Loss Per Share Despite Significant Stock Decline Petco WOOF Hovers Near Support Amid Modest Decline Manhattan Bridge Capital LOAN Holds Steady at 418 as Market Awaits Catalyst SCIIU Holds Steady at 1018 Consolidating Within Range as SPAC Unit Trades Flat Medtronic MDT Slides 1 as Markets Weigh Growth Prospects Key Support in View Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Highlight CNBC Morning Squawk SIDU Q1 2026 Earnings Space Company Reports Narrowed Loss as Stock Surges 24 UGI Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher GSK Q1 2026 Earnings EPS Beats Estimates Amid Revenue Data Gap CV Q1 2026 Earnings EPS Misses Estimates Amidst Challenging Quarter CanFite Biopharma Q4 2023 Earnings Significant EPS Surprise as Biotech Focuses on Clinical Pipeline Corvex Inc MOVE Q1 2026 Earnings EPS Beat Boosts Shares as Loss Narrows Atossa Therapeutics Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances MBX Q1 2026 Earnings Narrower Than Expected Loss as Clinical Progress Continues